The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer
- PMID: 29926189
- DOI: 10.1007/s00595-018-1684-1
The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer
Abstract
Purpose: This study investigated the predictors associated with early recurrence (i.e. within 12 months) after curative gastrectomy for gastric cancer (GC).
Methods: We evaluated the clinicopathological factors in 429 patients who underwent curative gastrectomy for GC without preoperative chemotherapy and analyzed these factors' associations with early recurrence.
Results: Of 429 patients, 57 experienced recurrences, which were associated with gender, diameter, depth of invasion, lymph node (LN) metastasis, the LN ratio (LNr; LNs with metastasis/dissected LNs), lymphatic invasion, vascular invasion, carbohydrate antigen 19-9 (CA19-9) levels, C-reactive protein levels and the neutrophil/lymphocyte ratio. Twenty-one patients (36.8%) recurred within 12 months. Early recurrence was associated with a high LNr (P = 0.0020) and high CA19-9 levels (P = 0.0415). The other factors were not significantly associated with early recurrence. The 12-month recurrence rate was 33.9% in patients with a high LNr and 1.9% in those with a low LNr and 20.3% in patients with high CA19-9 levels and 3.5% in those with low CA19-9 levels. The 12-month recurrence rate was 62.5% in patients with a high LNr and high CA19-9 levels, 18.4% in those with a high LNr or high-CA19-9 levels, and 1.4% in those with a low LNr and low CA19-9 levels.
Conclusion: LNr ≥ 0.15 and CA19-9 ≥ 37 U/ml were effective surrogate markers for predicting early recurrence.
Keywords: CA19-9; Early recurrence; Gastric cancer; Lymph node ratio.
Similar articles
-
Span-1 and CA19-9 as Predictors of Early Recurrence and Lymph Node Metastasis for Patients with Invasive Pancreatic Cancer after Pancreatectomy.Am Surg. 2018 Jan 1;84(1):109-113. Am Surg. 2018. PMID: 29428036
-
Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.Dig Dis Sci. 2006 Nov;51(11):2081-6. doi: 10.1007/s10620-006-9166-5. Epub 2006 Sep 29. Dig Dis Sci. 2006. PMID: 17009116
-
Prognostic value of postoperative CA19-9 normalization in patients with advanced gastric cancer.Hepatogastroenterology. 2013 Mar-Apr;60(122):240-3. doi: 10.5754/hge12585. Hepatogastroenterology. 2013. PMID: 22975648
-
Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer.BMC Surg. 2022 Jun 3;22(1):213. doi: 10.1186/s12893-022-01667-z. BMC Surg. 2022. PMID: 35655198 Free PMC article. Review.
-
[A case of jejunal carcinoma presenting high level or serum CA19-9].Nihon Shokakibyo Gakkai Zasshi. 1998 Jul;95(7):781-5. Nihon Shokakibyo Gakkai Zasshi. 1998. PMID: 9721520 Review. Japanese. No abstract available.
Cited by
-
Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.Int J Mol Sci. 2020 Jun 4;21(11):4012. doi: 10.3390/ijms21114012. Int J Mol Sci. 2020. PMID: 32512697 Free PMC article. Review.
-
Defining a Nomogram for Predicting Early Recurrence in Gastric Cancer Patients After Neoadjuvant Chemotherapy and Radical Gastrectomy.J Gastrointest Surg. 2023 Sep;27(9):1766-1777. doi: 10.1007/s11605-023-05697-7. Epub 2023 May 23. J Gastrointest Surg. 2023. PMID: 37221389 Clinical Trial.
-
Gastric Cancer: An Up-to-Date Review with New Insights into Early-Onset Gastric Cancer.Cancers (Basel). 2024 Sep 15;16(18):3163. doi: 10.3390/cancers16183163. Cancers (Basel). 2024. PMID: 39335135 Free PMC article. Review.
-
The Prognostic Value of Postoperative Lymph Node Ratio in Gastric Adenocarcinoma Patients Treated With Neoadjuvant Chemotherapy.Cureus. 2021 Apr 22;13(4):e14639. doi: 10.7759/cureus.14639. Cureus. 2021. PMID: 34046274 Free PMC article.
-
Nomogram for predicting overall survival after curative gastrectomy using inflammatory, nutritional and pathological factors.Clin Transl Oncol. 2024 Apr;26(4):1001-1011. doi: 10.1007/s12094-023-03340-0. Epub 2023 Nov 24. Clin Transl Oncol. 2024. PMID: 37996667
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous